RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Myriad Genetics Incorporated

A collection of news and information related to Myriad Genetics Incorporated published by this site and its partners.

Top Myriad Genetics Incorporated Articles see all

Displaying items 1-5
  • Genes are complex; gene patents might be more so

     
    Genetic research breakthroughs have come to be expected -- greeted with a sense of inevitability and the quiet assurance that science will ultimately puzzle out, then cure, human disease. But how those breakthroughs actually yield benefits is complicated. An e
  • ACLU asks Supreme Court to reconsider gene patenting case

    ACLU asks Supreme Court to reconsider gene patenting case
    The American Civil Liberties Union has asked for a second time that the Supreme Court invalidate Myriad Genetics Inc.'s patents on two genes associated with hereditary breast and ovarian cancers, the latest salvo in a case with broad consequences for...

    Gene patent case could impact patients, research

    Gene patent case could impact patients, research
    Every time a woman is tested for gene mutations linked to significantly higher rates of breast and ovarian cancer, her blood is sent to a lab in Utah. That's because Salt Lake City-based Myriad Genetics Inc. owns the patents to the BRCA 1 and BRCA 2...

    Genetic cancer test often urged for wrong women

    Genetic cancer test often urged for wrong women
    NEW YORK (Reuters) - Doctors are too quick to recommend expensive genetic counseling or testing for ovarian cancer, but at the same time often fail to refer women at high risk for the disease, government researchers said. Ovarian cancer isn't very common...

    Ban on patenting DNA cheers researchers

    Ban on patenting DNA cheers researchers
    Researchers hailed the Supreme Court ruling Wednesday that bans the patenting of human DNA, saying it would expand access to genetic testing for disease at lower cost to patients. In a unanimous decision, the justices said Myriad Genetics did not have...